Security key
G6724L116
OKYO Pharma Ltd - Ordinary Shares, no par value (OKYO)
CUSIP: G6724L116
Q3 2025 13F Holders as of 30 Sep 2025
- Security type / class
- Equity / Ordinary Shares, no par value
- Total 13F shares
- 2,570,815
- Total 13F value
- $5,141,930
- Share change
- -199,982
- SEC-reported price per share
- $2.00
- Number of holders
- 8
- Value change
- -$400,030
- Number of buys
- 4
- Number of sells
- 2
- Shares outstanding
- 52,174,143
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2025
Institutions
8
Top holders
8
OKYO full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2025
OKYO Pharma Ltd SEC filings
OKYO Pharma Ltd company facts
Broader feeds
Reporting periods
Holder history for CUSIP G6724L116
Recent filing periods:
Ownership snapshot
Top reported holders of OKYO - OKYO Pharma Ltd - Ordinary Shares, no par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Laura Natalia Monica Fonda
Disclosed value leader
Laura Natalia Monica Fonda
Comparable rows
6/6
Latest evidence
22 Jul 2025
13D/G
13F
Lead comparable stake: 5%
13D/G row: Laura Natalia Monica Fonda
Quick read
Laura Natalia Monica Fonda leads the comparable SEC ownership view at 5%.
6 of 6 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Laura Natalia Monica Fonda's linked filing trail.
Comparable ownership
Top 5
Laura Natalia Monica Fonda
5%
Dauntless Investment Group, LLC
5.2%
Cerity Partners LLC
0.02%
GEODE CAPITAL MANAGEMENT, LLC
0.02%
WEALTH ENHANCEMENT ADVISORY SERVI...
0.02%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 6 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Laura Natalia Monica Fonda |
13D/G
|
5%
|
$3,856,902
1,928,451 shares
|
$0 | 22 Jul 2025 |
| Dauntless Investment Group, LLC |
13F
Company
|
5.2%
|
$1,387,700
2,735,780 shares
|
— | 30 Jun 2025 |
| Cerity Partners LLC |
13F
Company
|
0.02%
|
$32,927
12,812 shares
|
— | 30 Jun 2025 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.02%
|
$31,071
12,090 shares
|
— | 30 Jun 2025 |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC |
13F
Company
|
0.02%
|
$27,800
10,000 shares
|
— | 30 Jun 2025 |
| UBS Group AG |
13F
Company
|
0%
|
$296
115 shares
|
— | 30 Jun 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
8
Shares
2,570,815
Rows available
8
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2025 vs Q1 2026 Across Filers
Q1 2026 holders
12
Q3 2025 holders
8
Holder diff
-4
| Investor | Q1 2026 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q1 2026 value | Q3 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend